Suleiman Al-Sweedan
苏莱曼·阿尔-斯威丹
MD, FAAP
Chief, Pediatric Hematology/Oncology儿童血液肿瘤科主任
👥Biography 个人简介
Suleiman Al-Sweedan is Chief of Pediatric Hematology/Oncology at King Hussein Cancer Center in Amman, one of the leading cancer centers in the Middle East. His expertise spans pediatric leukemia, lymphoma, and inherited blood disorders, and he has built regional training programs for pediatric oncologists.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Pediatric Leukemia Treatment
Implemented risk-adapted chemotherapy protocols for childhood ALL and AML in Jordan, achieving survival rates approaching those of high-income countries.
Inherited Blood Disorders
Advanced hematopoietic stem cell transplantation programs for sickle cell disease and thalassemia in the Middle East, reducing morbidity in affected children.
Pediatric Oncology Training
Established fellowship training programs in pediatric hematology/oncology at KHCC, producing specialists who serve across the Arab world.
Representative Works 代表性著作
Outcomes of childhood acute lymphoblastic leukemia treatment at King Hussein Cancer Center
Pediatric Blood & Cancer (2018)
Reported excellent outcomes for pediatric ALL at KHCC using modified international protocols adapted to Jordan's patient population and resources.
Hematopoietic stem cell transplantation for hemoglobinopathies in Jordan
Bone Marrow Transplantation (2016)
Described outcomes of HSCT for sickle cell and thalassemia at KHCC, demonstrating feasibility and success of transplant programs in the region.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 苏莱曼·阿尔-斯威丹 的研究动态
Follow Suleiman Al-Sweedan's research updates
留下邮箱，当我们发布与 Suleiman Al-Sweedan（King Hussein Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment